William DeVaul - Jan 14, 2022 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
General Counsel and Secretary
Signature
/s/ Robert Farrell as attorney-in-fact for William D. DeVaul
Stock symbol
MORF
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 06:06 PM
Previous filing
Dec 30, 2021
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Award $0 +57.8K $0.00 57.8K Jan 14, 2022 Common Stock 57.8K $44.75 Direct F1
transaction MORF Restricted Stock Units (RSU) Award $0 +13K $0.00 13K Jan 14, 2022 Common Stock 13K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F2 Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F3 The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025, and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.